{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:22:59Z","timestamp":1784640179630,"version":"3.55.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,10,15]]},"DOI":"10.2169\/internalmedicine.3082-23","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T22:16:36Z","timestamp":1709504196000},"page":"2833-2837","source":"Crossref","is-referenced-by-count":4,"title":["Evidence of Tosufloxacin Deposition in the Kidneys of a Patient Presenting with Crystal Nephropathy"],"prefix":"10.2169","volume":"63","author":[{"given":"Yuuki","family":"Ito","sequence":"first","affiliation":[{"name":"Depertment of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Mori","sequence":"additional","affiliation":[{"name":"Depertment of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Depertment of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Depertment of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Mori","sequence":"additional","affiliation":[{"name":"Depertment of Nephrology, Shizuoka General Hospital, Japan"},{"name":"Graduate School of Public Health, Shizuoka Graduate University of Public Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Chemistry, Faculty of Pharmacy, Meijo University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Todoroki","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Nagai","sequence":"additional","affiliation":[{"name":"Depertment of Nephrology, Shizuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Norrby SR. Optimal treatment strategies for acute exacerbations of chronic bronchitis: high-risk patients. Chemotherapy 47: 47-52, 2001.","DOI":"10.1159\/000049180"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Oyama S, Hosohata K, Inada A, et al. Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database. Ther Clin Risk Manag 14: 1599-1604, 2018.","DOI":"10.2147\/TCRM.S168696"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Okada H, Watanabe Y, Kotaki S, et al. An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate. Am J Kidney Dis 44: 902-907, 2004.","DOI":"10.1016\/S0272-6386(04)01089-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lien YH, Hansen R, Kern WF, et al. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis. Am J Kidney Dis 22: 598-602, 1993.","DOI":"10.1016\/S0272-6386(12)80936-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ramalakshmi S, Bastacky S, Johnson JP. Levofloxacin-induced granulomatous interstitial nephritis. Am J Kidney Dis 41: E7, 2003.","DOI":"10.1053\/ajkd.2003.50064"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sukpanichnant S, Hargrove NS, Kachintorn U, et al. Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient. Am J Surg Pathol 24: 129-135, 2000.","DOI":"10.1097\/00000478-200001000-00016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jacobs MR. Activity of quinolones against mycobacteria. Drugs 49: 67-75, 1995.","DOI":"10.2165\/00003495-199500492-00011"},{"key":"8","unstructured":"8. Kammoun K, Jarraya F, Makni S, et al. Ciprofloxacin-induced crystal nephropathy. Iran J Kidney Dis 8: 240-242, 2014."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamaguchi K. Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate. J Infect Chemother 7: 205-217, 2001.","DOI":"10.1007\/s101560170015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Goli R, Mukku KK, Raju SB, Uppin MS. Acute ciprofloxacin-induced crystal nephropathy with granulomatous interstitial nephritis. Indian J Nephrol 27: 231-233, 2017.","DOI":"10.4103\/0971-4065.200522"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moledina DG, Perazella MA. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol 12: 2046-2049, 2017.","DOI":"10.2215\/CJN.07630717"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sedlacek M, Suriawinata AA, Schoolwerth A, Remillard BD. Ciprofloxacin crystal nephropathy - a 'new' cause of acute renal failure. Nephrol Dial Transplant 21: 2339-2340, 2006.","DOI":"10.1093\/ndt\/gfl160"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liu Y, He Q, Wu M. Levofloxacin-induced crystal nephropathy. Nephrology (Carlton) 20: 437-438, 2015.","DOI":"10.1111\/nep.12405"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Matsubara R, Kibe T, Nomura T. Crystalline nephropathy caused by tosufloxacin. Pediatr Int 58: 1219-1221, 2016.","DOI":"10.1111\/ped.13116"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Niki Y. Pharmacokinetics and safety assessment of tosufloxacin tosilate. J Infect Chemother 8: 1-18, 2002.","DOI":"10.1007\/s101560200000"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/20\/63_3082-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T03:27:19Z","timestamp":1729308439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/20\/63_3082-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":15,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3082-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"article-number":"3082-23"}}